Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.

Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative ...

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited ...

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down ...

RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency’s public health mission continues.

Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.

The FDA has released a draft of new guidance addressing common FAQs about the development of potential CGT treatments.

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

The US FDA has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating acute leukaemia with KMT2A translocation.